Dose Escalation Study With Bispecific Antibodies in Adult Participants With Lupus Nephritis
Dose Escalation Study With Bispecific Antibodies in Adult Participants With Lupus Nephritis
Recruiting · NCT06975787 · Registry updated 2026-09-14Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Dose Escalation Study With Bispecific Antibodies in Adult Participants With Lupus Nephritis | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Skin and Connective Tissue Diseases, Urogenital Diseases, autoimmune disease, connective tissue disorder, glomerulonephritis, immune system disorder, kidney disorder, lupus nephritis, nephritis, systemic lupus erythematosus, urinary system disorder | Recruiting | Phase 1 | 2026-09-14 | NCT06975787 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Regeneron Pharmaceuticals | 238 |
19 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.